Obsessive-Compulsive Disorder (OCD) is an anxiety disorder in which people get recurring, unwanted thoughts, ideas, or sensations (obsessions) that make them feel driven to do something repetitively (compulsions). It is associated with a profoundly diminished quality of life, social isolation, and a substantial economic burden on society. The American Psychiatric Association (APA) states that females are affected at a slightly higher rate than men, and Obsessive-Compulsive Disorder affects people of all races and socio-economic backgrounds.
In a new 2017 publication, the World Health Organization’s ‘Depression and other common mental disorders’ report, OCD was included in the ‘anxiety disorders’ category. Obsessive-Compulsive Disorder ranks the tenth in the World Bank’s and WHO’s ten leading causes of disability and, in the case of women aged 15–44 years, Obsessive-Compulsive Disorder occupies the fifth position.
Get FREE sample copy at:
https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market
The Obsessive-Compulsive Disorder market report also covers emerging drugs, current treatment practices, Obsessive-Compulsive Disorder market share of the individual therapies, current and forecasted Obsessive-Compulsive Disorder Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Obsessive-Compulsive Disorder treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Obsessive-Compulsive Disorder Market Key Facts
According to the NIMH, Obsessive-Compulsive Disorder currently affects approximately 1 in 40 adults and 1 in 100 children in the U.S.
A study by Nakajima A. et al.,(2018), quoted that Obsessive-compulsive disorder (OCD) is a relatively common and frequently debilitating neuropsychiatric disorder that affects approximately 2% of the general population in Japan.
According to a study titled “Women Are at Greater Risk of Obsessive-Compulsive Disorder Than Men: A Meta-Analytic Review of Obsessive-Compulsive Disorder Prevalence Worldwide” conducted by Fawcettet E. J. al.,(2020), the overall aggregate current, period, and lifetime OCD prevalence estimates were 1.1%, 0.8%, and 1.3%, respectively.
Key Benefits of Obsessive-Compulsive Disorder Market Report
-
Obsessive-Compulsive Disorder market report provides an in-depth analysis of Obsessive-Compulsive Disorder Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
-
The Obsessive-Compulsive Disorder market report will help in developing business strategies by understanding the Obsessive-Compulsive Disorder Market trends & developments, key players and future market competition that will shape and drive the Obsessive-Compulsive Disorder market in the upcoming years.
-
The Obsessive-Compulsive Disorder market report covers Obsessive-Compulsive Disorder current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Obsessive-Compulsive Disorder market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Obsessive-Compulsive Disorder Market
The Obsessive-Compulsive Disorder market size is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of some emerging therapies during the forecast period.
The Obsessive-Compulsive Disorder market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Obsessive-Compulsive Disorder market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Obsessive-Compulsive Disorder market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Obsessive-Compulsive Disorder Epidemiology
The Obsessive-Compulsive Disorder epidemiology section covers insights about historical and current Obsessive-Compulsive Disorder patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Obsessive-Compulsive Disorder Drugs Uptake and Key Market Players
The Obsessive-Compulsive Disorder Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Obsessive-Compulsive Disorder market or expected to get launched in the market during the study period. The analysis covers Obsessive-Compulsive Disorder market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The Obsessive-Compulsive Disorder market size is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of some emerging therapies during the forecast period.
Some of the key companies in the Obsessive-Compulsive Disorder market include:
Pfizer
GlaxoSmithKline
Eli Lilly and Company
Biohaven Pharmaceuticals
And others.
Obsessive-Compulsive Disorder Therapies Covered:
ZOLOFT
Paxil
PROZAC
Trigriluzole
And many others.
Table of Content
1. Key Insights
2. Executive Summary
3. Obsessive-Compulsive Disorder Competitive Intelligence Analysis
4. Obsessive-Compulsive Disorder Market Overview at a Glance
5. Obsessive-Compulsive Disorder Disease Background and Overview
6. Obsessive-Compulsive Disorder Patient Journey
7. Obsessive-Compulsive Disorder Epidemiology and Patient Population
8. Obsessive-Compulsive Disorder Treatment Algorithm, Current Treatment, and Medical Practices
9. Obsessive-Compulsive Disorder Unmet Needs
10. Key Endpoints of Obsessive-Compulsive Disorder Treatment
11. Obsessive-Compulsive Disorder Marketed Products
12. Obsessive-Compulsive Disorder Emerging Therapies
13. Obsessive-Compulsive Disorder Seven Major Market Analysis
14. Attribute Analysis
15. Obsessive-Compulsive Disorder Market Outlook (7 major markets)
16. Obsessive-Compulsive Disorder Access and Reimbursement Overview
17. KOL Views on the Obsessive-Compulsive Disorder Market.
18. Obsessive-Compulsive Disorder Market Drivers
19. Obsessive-Compulsive Disorder Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Related Reports
Obsessive-Compulsive Disorder Epidemiology Forecast
DelveInsight’s Obsessive-Compulsive Disorder – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Obsessive-Compulsive Disorder in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Obsessive-Compulsive Disorder Pipeline Insights
Obsessive-Compulsive Disorder Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Obsessive-Compulsive Disorder market.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/